Rocaglamide sensitizes leukemic T cells to activation-induced cell death by differential regulation of CD95L and c-FLIP expression (Q34017088)

30 July 2017

Rocaglamide sensitizes leukemic T cells to activation-induced cell death by differential regulation of CD95L and c-FLIP expression (English)

1 reference

30 July 2017

1 reference

1 reference

J Y Zhu

1

1 reference

30 July 2017

M Giaisi

2

1 reference

30 July 2017

R Köhler

3

1 reference

30 July 2017

W W Müller

4

1 reference

30 July 2017

A Mühleisen

5

1 reference

30 July 2017

P Proksch

6

1 reference

30 July 2017

P H Krammer

7

1 reference

30 July 2017

M Li-Weber

8

1 reference

30 July 2017

17 April 2009

1 reference

Cell Death & Differentiation

30 July 2017

1 reference

30 July 2017

16

1 reference

30 July 2017

9

1 reference

30 July 2017

1289-1299

1 reference

https://scigraph.springernature.com/pub.10.1038/cdd.2009.42

30 July 2017

0 references

cites work

Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.42

Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.42

Death receptors in chemotherapy and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.42

Mitochondria as therapeutic targets for cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.42

Life and death in peripheral T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.42

Activation interferes with the APO-1 pathway in mature human T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.42

Concepts of activated T cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.42

Selective apoptosis of CD4+CD8+ thymocytes by the anti-Fas antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.42

Function and regulation of the CD95 (APO-1/Fas) ligand in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.42

cFLIP regulation of lymphocyte activation and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.42

Nuclear factor of activated T cells balances angiogenesis activation and inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.42

NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.42

NF-kappaB signals induce the expression of c-FLIP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.42

Resistance of short term activated T cells to CD95-mediated apoptosis correlates with de novo protein synthesis of c-FLIPshort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.42

c-FLIP protects mature T lymphocytes from TCR-mediated killing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.42

Potential of cyclopenta[b]benzofurans from Aglaia species in cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.42

The traditional Chinese herbal compound rocaglamide preferentially induces apoptosis in leukemia cells by modulation of mitogen-activated protein kinase activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.42

A novel AP-1 element in the CD95 ligand promoter is required for induction of apoptosis in hepatocellular carcinoma cells upon treatment with anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.42

An unexpected role for FosB in activation-induced cell death of T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.42

Cytostatic mechanism and antitumor potential of novel 1H-cyclopenta[b]benzofuran lignans isolated from Aglaia elliptica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.42

Transcription factors of the NFAT family: regulation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.42

c-Jun NH(2)-terminal kinase inhibits targeting of the protein phosphatase calcineurin to NFATc1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.42

T-cell receptor stimulation elicits an early phase of activation and a later phase of deactivation of the transcription factor NFAT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.42

DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.42

Regulating the regulators: control of protein ubiquitination and ubiquitin-like modifications by extracellular stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.42

The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.42

Silvestrol and episilvestrol, potential anticancer rocaglate derivatives from Aglaia silvestris

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.42

Flow cytometry of apoptotic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.42

FLICE is predominantly expressed as two functionally active isoforms, caspase-8/a and caspase-8/b.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.42

Monoclonal antibody-mediated tumor regression by induction of apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.42

HTLV-1 Tax protects against CD95-mediated apoptosis by induction of the cellular FLICE-inhibitory protein (c-FLIP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.42

Human tumor xenografts as model for drug testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.42

Acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.42

7 January 2021

Up-regulation of c-FLIP short by NFAT contributes to apoptosis resistance of short-term activated T cells

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.42

7 January 2021

TCR-mediated up-regulation of c-FLIPshort correlates with resistance toward CD95-mediated apoptosis by blocking death-inducing signaling complex activity

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.42

7 January 2021

Rocaglamide derivatives are immunosuppressive phytochemicals that target NF-AT activity in T cells

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.42

7 January 2021

A role for the p38 MAP kinase pathway in the nuclear shuttling of NFATp

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.42

7 January 2021

Novel Egr/NF-AT composite sites mediate activation of the CD95 (APO-1/Fas) ligand promoter in response to T cell stimulation

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.42

7 January 2021

X-Ray crystal structure of rocaglamide, a novel antileulemic 1H-cyclopenta[b]benzofuran from Aglaia elliptifolia

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.42

7 January 2021

Identifiers

DOI

10.1038/CDD.2009.42

1 reference

30 July 2017

1 reference